Company Filing History:
Years Active: 2009
Title: Sabine Bonnenfant: Innovator in Anti-Integrase Medicaments
Introduction
Sabine Bonnenfant is a notable inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of integrase-inhibiting medicaments. Her work focuses on combating retroviral pathologies, including AIDS.
Latest Patents
Sabine Bonnenfant holds a patent for the "Use of quinoline derivatives with anti-integrase effect and applications thereof." This invention pertains to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives to produce medicaments that inhibit integrase, effectively blocking viral replication during critical stages of the viral life cycle.
Career Highlights
Throughout her career, Bonnenfant has worked with prominent organizations such as Bioalliance Pharma and Institut Gustave Roussy. Her expertise in medicinal chemistry has positioned her as a key player in the development of innovative treatments for retroviral diseases.
Collaborations
She has collaborated with esteemed colleagues, including Aurélie Mousnier and Catherine Dargemont, contributing to the advancement of research in her field.
Conclusion
Sabine Bonnenfant's innovative work in the development of anti-integrase medicaments showcases her dedication to improving treatments for retroviral pathologies. Her contributions continue to impact the field of medicinal chemistry significantly.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.